NASDAQ:PSTV

Plus Therapeutics Stock Insider Trading

etoro logo Buy PSTV
*Your capital is at risk
$5.42
-0.0500 (-0.91%)
At Close: Jun 03, 2026

Plus Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 31.87M and sold 0 PSTV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 31.87M shares
Sell 0 shares
100% Buy Activity
Moderate Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
May 14, 2026
Buy
Stock Option (Right to Buy)
A-Award
Hedrick Marc H
Chief Executive Officer
CEO / President 23 834
Value: $137.3K
May 14, 2026
Buy
Restricted Stock Units
A-Award
Hedrick Marc H
Chief Executive Officer
CEO / President 23 834
Value: $137.3K
May 14, 2026
Buy
Stock Option (Right to Buy)
A-Award
Sims Andrew John Hugh Macintyre
Chief Financial Officer
C-Suite Officer 3 443
Value: $19.8K
May 14, 2026
Buy
Stock Option (Right to Buy)
A-Award
Andrews Ronald Asbury
Director
Director 3 686
Value: $21.2K
May 14, 2026
Buy
Restricted Stock Units
A-Award
Andrews Ronald Asbury
Director
Director 3 686
Value: $21.2K
May 14, 2026
Buy
Stock Option (Right to Buy)
A-Award
Guse Kyle
Director
Director 3 686
Value: $21.2K
May 14, 2026
Buy
Stock Option (Right to Buy)
A-Award
Hawkins Richard J
Director
Director 3 686
Value: $21.2K
May 14, 2026
Buy
Restricted Stock Units
A-Award
Hawkins Richard J
Director
Director 3 686
Value: $21.2K
May 14, 2026
Buy
Stock Option (Right to Buy)
A-Award
Van Es-johansson An
Director
Director 3 686
Value: $21.2K
May 14, 2026
Buy
Restricted Stock Units
A-Award
Van Es-johansson An
Director
Director 3 686
Value: $21.2K
May 14, 2026
Buy
Restricted Stock Units
A-Award
Guse Kyle
Director
Director 3 686
Value: $21.2K
May 14, 2026
Buy
Restricted Stock Units
A-Award
Clowes Howard
Director
Director 3 686
Value: $21.2K
May 14, 2026
Buy
Stock Option (Right to Buy)
A-Award
Clowes Howard
Director
Director 3 686
Value: $21.2K
May 14, 2026
Buy
Stock Option (Right to Buy)
A-Award
Andrews Ronald Asbury
Director
Director 1 600
Value: $9K
May 14, 2026
Buy
Restricted Stock Units
A-Award
Sims Andrew John Hugh Macintyre
Chief Financial Officer
C-Suite Officer 3 443
Value: $19.8K
Apr 20, 2026
Buy
Restricted Stock Units
A-Award
Daniels Eric Joseph
Chief Development Officer
Officer 20 000
Value: $146.0K
Apr 20, 2026
Buy
Stock Option (Right to Buy)
A-Award
Daniels Eric Joseph
Chief Development Officer
Officer 20 000
Value: $146.0K
Apr 20, 2026
Buy
Common Stock
Daniels Eric Joseph
Chief Development Officer
Officer 0
Value: $0
Apr 01, 2026
Buy
Common Stock
M-Exempt
Hedrick Marc H
Chief Executive Officer
CEO / President 201 632
Value: $785.4K
Apr 01, 2026
Buy
Restricted Stock Units
M-Exempt
Hedrick Marc H
Chief Executive Officer
CEO / President 201 632
Value: $785.4K
Apr 01, 2026
Buy
Common Stock
M-Exempt
Sims Andrew John Hugh Macintyre
Chief Financial Officer
C-Suite Officer 38 323
Value: $149.3K
Apr 01, 2026
Buy
Common Stock
M-Exempt
Sims Andrew John Hugh Macintyre
Chief Financial Officer
C-Suite Officer 29 129
Value: $113.5K
Apr 01, 2026
Buy
Restricted Stock Units
M-Exempt
Sims Andrew John Hugh Macintyre
Chief Financial Officer
C-Suite Officer 38 323
Value: $149.3K
Apr 01, 2026
Buy
Restricted Stock Units
M-Exempt
Sims Andrew John Hugh Macintyre
Chief Financial Officer
C-Suite Officer 29 129
Value: $113.5K
Apr 01, 2026
Buy
Restricted Stock Units
M-Exempt
Hedrick Marc H
Chief Executive Officer
CEO / President 159 681
Value: $622.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PLUS THERAPEUTICS, INC.
Plus Therapeutics
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to d...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE